ITP
Iron Triangle Partners Portfolio holdings
AUM
$632M
This Quarter Return
+3.24%
1 Year Return
+26.53%
3 Year Return
+134.07%
5 Year Return
+312.1%
10 Year Return
–
AUM
$572M
AUM Growth
+$572M
(-7.8%)
Cap. Flow
-$68.7M
Cap. Flow
% of AUM
-12.02%
Top 10 Holdings %
Top 10 Hldgs %
54.05%
Holding
34
New
9
Increased
5
Reduced
12
Closed
6
Top Buys
| 1 |
Charles River Laboratories
CRL
|
$39.8M |
| 2 |
Sanofi
SNY
|
$34.2M |
| 3 |
HCA Healthcare
HCA
|
$25.7M |
| 4 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$21.8M |
| 5 |
Insulet
PODD
|
$18.4M |
Top Sells
| 1 |
AbbVie
ABBV
|
$53.6M |
| 2 |
Humana
HUM
|
$31.5M |
| 3 |
AstraZeneca
AZN
|
$28.9M |
| 4 |
DexCom
DXCM
|
$28.2M |
| 5 |
Repligen
RGEN
|
$28.1M |
Sector Composition
| 1 | Healthcare | 98.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OHPAU
26
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $9.87M | 1.72% |
999,513
| – | – |
|
27
Stereotaxis
STXS
$246M
| $3.05M | 0.53% |
1,696,599
-10,089
| -0.6% | -$18.2K |
|
28
Legend Biotech
LEGN
$6.64B
| – | – |
-495,329
| Closed | -$27.2M |
|
29
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
|
SLGC
30
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| – | – |
-1,000,000
| Closed | -$4.52M |
|
|
31
AbbVie
ABBV
$374B
| – | – |
-350,000
| Closed | -$53.6M |
|
|
32
AstraZeneca
AZN
$255B
| – | – |
-437,477
| Closed | -$28.9M |
|
33
CONMED
CNMD
$1.64B
| – | – |
-260,000
| Closed | -$24.9M |
|
34
Karyopharm Therapeutics
KPTI
$61.4M
| – | – |
-1,100,000
| Closed | -$4.96M |
|